Cargando…

Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial

AIM: The aim of this clinical trial is to compare the clinical and radiographic success of Aloe vera and formocresol (FC) as a pulpotomy medicament in primary molars. MATERIALS AND METHODS: A total of 72 asymptomatic or symptomatic vital primary molars were selected and were assigned to two groups:...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanyam, Divya, Somasundaram, Sujatha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366759/
https://www.ncbi.nlm.nih.gov/pubmed/32742090
http://dx.doi.org/10.5005/jp-journals-10005-1724
Descripción
Sumario:AIM: The aim of this clinical trial is to compare the clinical and radiographic success of Aloe vera and formocresol (FC) as a pulpotomy medicament in primary molars. MATERIALS AND METHODS: A total of 72 asymptomatic or symptomatic vital primary molars were selected and were assigned to two groups: group II: Buckley's FC, group II: Aloe vera gel. The clinical and radiographic success were evaluated using Zurn and Seale criteria. The data were statistically analyzed using the Chi-square test. RESULTS: At three and 6 months follow-up, the clinical success rate of Aloe vera and FC was equally effective. Aloe vera showed a higher radiographic success rate compared to FC (p > 0.05). At 6 months follow-up, FC showed a higher radiographic success rate compared to Aloe vera (p > 0.05). CONCLUSION: The clinical and radiographic success of both groups were equally effective at the end of 6 months follow-up. Aloe vera can be considered as an alternative pulpotomy medicament to FC. But, further long-term follow-up studies and histological studies are required. HOW TO CITE THIS ARTICLE: Subramanyam D, Somasundaram S. Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial. Int J Clin Pediatr Dent 2020;13(2):138–143.